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Abstract
Background: Chagas disease, caused by the flagellate parasite Trypanosoma cruzi affects 8–10 million people in Latin
America. The mechanisms that underlie the development of complications of chronic Chagas disease, characterized
primarily by pathology of the heart and digestive system, are not currently understood. To identify possible host genetic
factors that may influence the clinical course of Chagas disease, Human Leucocyte Antigen (HLA) regional gene
polymorphism was analyzed in patients presenting with differing clinical symptoms.
Methodology: Two hundred and twenty nine chronic Chagas disease patients in Santa Cruz, Bolivia, were examined by
serological tests, electrocardiogram (ECG), and Barium enema colon X-ray. 31.4% of the examinees showed ECG alterations,
15.7% megacolon and 58.1% showed neither of them. A further 62 seropositive megacolon patients who had undergone
colonectomy due to acute abdomen were recruited. We analyzed their HLA genetic polymorphisms (HLA-A, HLA-B, MICA,
MICB, DRB1 and TNF-alpha promoter region) mainly through Sequence based and LABType SSO typing test using LUMINEX
Technology.
Principal Findings: The frequencies of HLA-DRB1*01 and HLA-B*14:02 were significantly lower in patients suffering from
megacolon as well as in those with ECG alteration and/or megacolon compared with a group of patients with indeterminate
symptoms. The DRB1*0102, B*1402 and MICA*011 alleles were in strong Linkage Disequilibrium (LD), and the HLA-DRB1*01-
B*14-MICA*011haplotype was associated with resistance against chronic Chagas disease.
Conclusions: This is the first report of HLA haplotype association with resistance to chronic Chagas disease.
Citation: del Puerto F, Nishizawa JE, Kikuchi M, Roca Y, Avilas C, et al. (2012) Protective Human Leucocyte Antigen Haplotype, HLA-DRB1*01-B*14, against
Chronic Chagas Disease in Bolivia. PLoS Negl Trop Dis 6(3): e1587. doi:10.1371/journal.pntd.0001587
Editor: Helton da Costa Santiago, National Institutes of Health, United States of America
Received September 2, 2011; Accepted February 11, 2012; Published March 20, 2012
Copyright:  2012 del Puerto et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported in part by the Grant-in-Aid for 21c COE program (2003–2008), the Global Center of Excellence (GCOE) Program (2008–2011),
Nagasaki University and Grant-in-Aid for Research A (23256003) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hiraken@nagasaki-u.ac.jp
Introduction
Following an extensive control program consisting of vector
control, serological screening in blood banks and identification and
treatment of congenital transmission, the estimated number of
people infected with Trypanosoma cruzi, the causal agent of Chagas
disease in Latin America, has fallen from approximately 20 million
in 1981 to around 8–10 million in 2009 [1,2]. Most of the
seropositive patients are chronically infected and more than
10,000 deaths are estimated to occur annually from the disease
[1,3,4].
Cardiac myositis and autonomous neuroplexus degeneration of
the digestive tract are major histopathological alterations that can
arise during Chagas disease, and may lead to cardiac failure,
digestive abnormalities, megacolon or megaesophagus. Based on
these pathologies, there are often considered to be three major
clinical forms of Chagas disease; cardiac, digestive and indetermi-
nate [5,6]. This variation in pathological manifestation has been
reported to relate to differences in host immune response, such as
the ability to control parasitaemia, the strength of inflammatory
reactions, and the induction of autoimmune like responses [7–11].
Indeterminate phase T-cells have been reported to correspond
with modulatory responses such as increased IL-10 production by
CD4
+CD28
2 T cells and the expression of CTLA-4, a ligand that
is involved in modulation of T-cell responses by CD8
+ T-cells
[12,13]. Additionally, the unregulated production of IFN-gamma
by CD8
+ T-cells in cardiac Chagas disease patients has been
reported, which might result in the destruction of heart tissue due
to its cytotoxic effect [12].
The highly polymorphic HLA Class I and II molecules
determine the efficiency of T. cruzi epitope presentation to T
lymphocytes that could affect the clinical course of Chagas disease
www.plosntds.org 1 March 2012 | Volume 6 | Issue 3 | e1587[14,15]. Several HLA alleles and haplotypes have been reported to
be associated with Cardiac Chagas disease in Chile, Venezuela,
Brazil and Guatemala [16–18]. The HLA region contains not only
classical HLA genes but a wide variety of immunologically
relevant genes, such as nonclassical class I genes (MICA, MICB)
[19,20], and class III genes (TNF-alpha, beta), that may be
involved in pathogenesis [21,22].
In the present study, we investigated HLA class I (A, B, MICA,
MICB), Class II (DRB1) and Class III (TNF-alpha) gene
polymorphism in seropositive chronic Chagas patients in Bolivia,
characterized by electrocardiogram (ECG), barium enema colon
X-ray examinations and/or surgical operation.
Materials and Methods
Patients
The study subjects were described previously [23]. Two
hundred and ninety one patients with chronic Chagas disease
(136 men and 155 women, mean age 45 years) were recruited
from the Centro Nacional de Enfermedades Tropicales (CENE-
TROP) (91 men and 119 women), Hospital Primero de Mayo (12
men and 7 women) and from post-operative patients at the
Hospital Universitario Japone ´s (HUJ) (33 men and 29 women) in
Santa Cruz, Bolivia.
Upon medical examination of patients other than the HUJ
patients, if serological tests (Indirect Haemaglutination assay (IHA)
and Indirect Immunofluorescence test (IIF) [3]) were positive, they
were asked to participate in the study and signed informed consent
was obtained. Informed consent was also obtained for the HUJ
post-operative patients, using the same protocol.
ECG abnormalities were diagnosed based on the Minnesota
Code Criteria and were confirmed independently by two
cardiologists. Colon X-ray with barium enema examination was
performed for the detection of megacolon. To exclude the
possibility of including individuals who were asymptomatic upon
examination, but who may not have had adequate time post-
infection for symptoms to become apparent, those under 30 years
of age were excluded.
Finally, 229 seropositive Chagas outpatients in Santa Cruz,
Bolivia, were examined by ECG and/or barium enema colon X-
ray as shown in Table 1. The 62 post-operational patients from
HUJ were confirmed to be suffering from Chagas megacolon
during the admission period.
The experimental protocol was approved by the Institutional
Ethical Review Committee of the Institute of Tropical Medicine,
Nagasaki University (No. 0210170018) and the Centro Nacional
de Enfermedades Tropicales (CENETROP).
DNA extraction
Genomic DNA was extracted from 10 mL of whole blood
containing 10 mM EDTA using a DNA extraction kit (QIAGEN
GmbH, FRG) and was stored at 220uC until use.
Typing of MICA, MICB, TNF alpha promoter region and
GCT repeat polymorphism in the MICA gene
transmembrane region (MICA-TM)
MICA, MICB, TNF-alpha promoter region and MICA-TM
typing was performed as previously described [19–21]. Sequences
were obtained from a 3730 DNA Analyzer (Applied Biosystems,
USA) and submitted to the Assign- software ATF (Conexio
Genomics ATF, Australia) for allele identification. The TNFP
alleles were determined according to Higuchi T et al (1998) and
Ubalee R et al (2001) [21,22].
MICA-TM alleles were typed by sequencing on a 3730 DNA
analyzer (Applied Biosstems, USA) and analyzed with the
GeneMapper Software Version 3.7 (Applied Biosystems, USA).
The fluorescent primers, 59 F (GCC CAG TGT ATA ACA AGT
CCC-6-FAM) and 39 R (CCT TAC CAT CTC CAG AAA CTG
C) were used.
HLA-A, HLA-B, HLA-DRB1 typing
Typing was carried out according to the manufacturer’s
specification for LABType SSO Typing, testing for each locus
using LUMINEX Technology (ONE LAMBDA, INC, USA) and
the retrieved output was analyzed by HLA Fusion software (ONE
LAMBDA, INC, USA) for allele identification.
Statistical analysis
Statistical analysis was performed at the two and four digits
levels. Allele frequencies less than 5% were removed from the
analysis. The statistical significance and odds ratio (OR) of allele
frequencies between each group was determined by Chi square
and Fisher’s exact tests using the StatsDirec software (StatsDirect
Ltd, UK). P-values were considered significant when ,0.05
following Bonferoni correction (Pc). Hardy-Weinberg Equilibrium,
linkage disequilibrium (LD) and Haplotype analyses were
calculated with PyPopWin32.0.7.0 software [24].
Results
Frequencies of HLA-B*14 and HLA-DRB1*01 significantly
decreased in megacolon patients compared with
indeterminate patients
In the two digits analysis (Table S1, S3, S5), we observed a
significant decreased frequency of alleles DRB1*01 and B*14 in
the megacolon patients compared with indeterminate patients
(Table 2). The frequency of HLA-B*14 was also significantly lower
in the patients with ECG alteration compared to the indeterminate
patients. In the four digits analysis (Table S2, S4, S6), DRB1*01:01,
Author Summary
Chronic Chagas disease consists of four different forms
categorized on the basis of their clinical manifestations,
namely; cardiac, digestive, cardiodigestive and indetermi-
nate. In Latin America, there are 8–10 million seropositive
persons who are at risk of, or have already developed
serious clinical complications and who have limited access
to effective treatment. The cardiac and digestive forms are
characterized by tissue damage caused by persistent
infection of Trypanosoma cruzi and are thought to be
modulated by host immunity. In our large scale screening
for chronic Chagas disease in Santa Cruz, Bolivia, hearts
and colons of 229 seropositive patients were examined.
We found 31.4% of patients had abnormal electrocardio-
grams (ECGs), 15.7% presented with megacolon, 5.2% had
a combination of abnormal ECG and megacolon, and
58.1% were of indeterminate status. Previously, we
attempted to ascertain whether parasite genetic polymor-
phism might account for the differences in clinical
manefestations, by analyzing parasite DNA taken from
the same study group (with the addition of a further 62
megacolon post-operational patients). We found no
relationships between parasite lineages and clinical
disease form. The present study reveals that host HLA
polymorphisms associate with clinical manifestations of
Chagas.
HLA Association with Chronic Chagas Disease
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frequencies in the megacolon patients compared with the indeter-
minate patients. The frequency of the HLA-B*14:02 allele was
significantly lower in the ECG alteration and/or megacolon patients
compared with those of indeterminate symptoms (Table 2). The
frequency of MICA*011 was also significantly lower in the
complication positive groups (Table 2, S7).
TNF-alpha promoter region polymorphism and MICB
alleles
None of the TNF-alpha promoter region and MICB (Table S11
and S8) alleles tested here were significantly associated with the
clinical groups compared with the indeterminate group.
Linkage disequilibrium (LD) between the alleles of
HLA-DRB1, A, B, and MICA, B loci
Linkage disequilibrium (LD) was calculated for all combinations
of alleles (Table S1, Table S2, Table S3, Table S4, Table S5,
Table S6, Table S7, Table S8, Table S9), and significantly strong
LDs was observed between the alleles, HLA-DRB1*01, A*33:01,
B*14:02 and MICA*011 as shown in Table 3. Except for HLA-
A*33:01, all the linkage group alleles showed the same tendency of
being associated with protection against megacolon (Table 2).
HLA-A*01:01 showed strong LD with HLA-B*08:01, DRB1*
0301 and MICB*008. Although HLA-A*01:01 showed a non-
significant tendency of association with non-megacolon patients,
none of the LD group alleles showed any similar tendency
(Table 2). No LD was observed between any HLA alleles and
TNF-alpha promoter haplotypes.
Discussion
We have previously shown that there was no association between
T. cruzi lineage or sub lineage and the clinical manifestation of
Chagas disease in samples from Bolivia [23]. Here, we have
analysed the same samples in order to determine if there were any
associations between clinical disease and host genetic variation. We
analysed polymorphic genes located in the MHC region, consisting
of three sub regions; class I, II and III. Human MHC, HLA class I
and II molecules play a crucial role in determining individual
acquired immune responsiveness through the presentation of
pathogen-derived peptides to CD8
+ and CD4
+ T-cells. In the class
III sub region, there are a variety of genes related to immunity such
as complement, TNF-alpha, Lymphotoxin, etc. [24].
Our study revealed that the HLA-DRB1*01-B*14-MICA*011
haplotype was significantly associated with protection from
Chagasic megacolon. As the linkage disequilibrium between the
HLA-B*14 and DRB1*01 was strong (Table 3), it was difficult to
determine the primary associated locus within the haplotype.
HLA-class I is the antigen-presenting molecule on the cell-
surface of infected host cells which stimulates microbe-derived
antigen specific CD8
+ T-cells. Therefore, HLA-B*14 itself could
be directly related to protective T-cell immunity as was suggested
by the Chagas disease mouse model [25].
If HLA-B*14 is more efficient at stimulating protective T-cells
through the binding of antigenic peptides, other HLA-class I
molecules that share the same antigen binding motif should show
the same protective association. HLA-B*14 consists of three 4-digit
alleles, HLAB*14:01, 14:02 and 14:06 that share the same antigen
binding motifs but the latter two alleles are so rare that it was
impossible to analyse their effect. As the HLA-B*14 alleles belong
to the B27 supertype group that share the same anchoring residues
in the peptide binding groove, we analyzed the member alleles
B*38:01, 39:04, 39:05. 39:06, 39:14, 48:01, 48:03 for their total
effect on protection against complication, and found no association
(Tables S6 and S10) [26]. This finding did not, therefore, support
the hypothesis that the association between HLA-B*14 and
protection against clinical Chagas disease is driven by the ability
of the gene product to more effectively stimulate protective T-cells
than other alleles of this gene.
T h ep e r i p h e r a lh u m a na n dm i c eC D 8
+T-cells reactive to
Trypanosome antigens have been identified [27]. Interestingly, HLA-
A*02:01 restricted epitopes from cruzipain and FL-160 were
frequently recognized by PBMC of patients with Cardiopathy [28].
Moreover, an HLA-A2 tetramer experiment showed that the number
of IFN-gamma producing amastigote-specific CD8
+ T-cells inversely
correlated with the severity of the disease [29]. It will be interesting to
see if the same phenomenon occurred in the HLA-B*14 patients.
Immuno-regulatory mechanisms have been reported to be
associated with clinical forms including Treg cells [30], NKT cells
and NK cells [31]. Whereas the HLA involvement in the induction
of Treg cells is not yet clear, HLA-class I can interact with NK cells
to suppress their activity through various inhibitory receptors such
as KIR. HLA-B*14 belongs to the Bw6 family, the members of
which preferentially stimulate specific members of the KIR family
[32,33], which could regulate NK cell activity during inflammation.
HLA-non classical class I, MICA*011, which was closely linked to
HLA-B*14 and DRB1*01 might also be functional as MICA is
Table 1. Subjects.
Grouping Criteria IIF
f HAA
Q Mega colon* ECG alteration** N=291 Male/Female Age ±SD
Indeterminate ++22 70 31/39 4368.5
Megacolon +++ 2 36 17/19 47612.0
Megacolon +++ NE 45 26/19 56616.6
ECG alteration ++2 + 40 20/20 3969.8
ECG alteration ++NE + 20 10/10 41610.6
Megacolon and ECG alteration +++ + 17 6/11 48614.1
Not determined ++NE 2 36 15/21 4268.8
Not determined ++2 NE 27 11/16 4367.5
*Examination of Colon by Barium enema and X-ray: +; Megacolon, 2; no abnormality, NE; not examined.
**Examination of Electrocardiogram. +; typical alterations, 2; no alteration, NE; not examined.
fIndirect Immunofluorescence Test.
QHaemaglutination Assay.
doi:10.1371/journal.pntd.0001587.t001
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phenomenon that could relate to megacolon [34].
HLA-class II can present antigen to CD4
+ T-cells so HLA-
DRB1*01 may also be directly involved in the pathogenesis as well
as HLA-B*14. Many autoimmune diseases are reported to be
associated with specific HLA-class II alleles [35]. Auto-reactive
processes that involve the activation of cytokine producing T-cells
may occur during infection. As was previously suggested,
autoimmune mechanisms in the pathogenesis of chronic Chagas
heart and colon may be regulated by the HLA-class II.
We analyzed 4-digit HLA-DRB1 alleles for association with
Chagas disease clinical manifestations. As shown in Table 2, the
HLA-DRB1*01 group included three alleles, DRB1*01:01, 01:02,
01:03 and all of them showed the same protective tendency when
compared between the megacolon and indeterminate symptom
groups. As two of them, 01:01 and 01:02 shared the same peptide-
binding motif [36], we considered that the HLA-DR molecule
itself was functionally related to resistance to megacolon. It was
previously reported that the DRB1*01 allele was associated with
susceptibility to Chagas cardiomyopathy in Venezuela [37]. This
opposite association to the megacolon resistance observed in the
present work requires further clarification.
Despite the strong LD shown within the HLA-DRB1*01-B*14
haplotype, there was no strong linkage between TNF-alpha
promoter alleles that may influence the levels of its production by
immune cells [21]. However, between HLA-DRB1 and HLA-B
loci, 1270 kb of class III sub region containing more than 60 genes
such as complements, heat shock proteins, 21-hydroxylase, are
present that might be relevant to pathogenesis. The HLA-
B*14:02-DRB1*01:02 haplotype was reported to be associated
with V281L polymorphism in 21-hydroxylase in African-Ameri-
can and Caucasian populations [38]. The same kind of
Table 2. Two-digit and four-digit alleles association with Clinical Manifestations of Chagas disease.
HLA locus
Indeterminate
(N=70)
Megacolon
(N=98)
ECG Alteration
(N=77)
ECG alteration and/or
Megacolon (N=158)
HLA-DRB1* n (%) n (%) n (%) n (%) Pv Pc OR [95%CI]
01 12 (17.1) 1 (1.0) 9 (11.7) 10 (6.3) 0.0001* 0.001* 0.049 [0.001–0.358]*
01:01 4 (5.7) 0 (0.0) 2 (2.6) 2 (1.3)
01:02 8 (11.4) 1 (1.0) 3 (3.9) 4 (2.5) 0.011*
0.009
f
NS*
NS
f
0.089 [0.002–0.687] *
0.200 [0.043–0.790]
01:03 1 (1.4) 0 (0.0) 4 (5.2) 4 (2.5)
03:01
Q 4 (5.7) 10 (10.2) 3 (3.9) 13 (8.2)
HLA-A* n (%) n (%) n (%) n (%) Pv Pc OR [95%CI]
01 10 (14.3) 4 (4.1) 16 (20.8) 20 (12.7) 0.024* NS* 0.250 [0.056–0.943]*
01:01
Q 4 (5.7) 3 (3.1) 14 (18.2) 17 (10.8) 0.024** NS** 3.667 [1.067–15.993]**
01:06 4 (5.7) 1 (1.0) 1 (1.3) 1 (0.6)
01:07 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.6)
01:14 2 (2.9) 0 (0.0) 1 (1.3) 0 (0.0)
33:01 1 (1.4) 5 (5.1) 1 (1.3) 6 (3.8)
HLA-B* n (%) n (%) n (%) n (%) Pv Pc OR [95%CI]
14 10 (14.3) 2 (2.0) 3 (3.9) 5 (3.2) 0.004*
0.040**
0.003
f
0.049*
NS**
0.040
f
0.125 [0.013–0.623]*
0.245 [0.042–1.010]**
0.196 [0.051–0.666]
f
14:01 1 (1.4) 0 (0.0) 2 (2.6) 2 (1.3)
14:02 8 (11.4) 2 (2.0) 1 (1.3) 3 (1.9) 0.018*
0.014**
0.004
f
NS*
NS**
0.049
f
0.161 [0.016–0.854]*
0.103 [0.002–0.805]**
0.149 [0.025–0.675]
f
14:06 1 (1.4) 0 (0.0) 0 (0.0) 0 (0.0)
08:01
Q 4 (5.7) 6 (6.1) 5 (6.5) 11 (7.0)
MICA* n (%) n (%) n (%) n (%) Pv Pc OR [95%CI]
011 6 (8.6) 0 (0.0) 1 (1.3) 1 (0.6) 0.005*
0.004
f
NS*
0.048
f
0.050 [0.000–0.832]*
0.069 [0.001–0.584]
f
034 1 (1.4) 4 (4.1) 2 (2.6) 6 (3.8)
MICB* n (%) n (%) n (%) n (%) Pv Pc OR [95%CI]
008
Q 9 (12.9) 5 (5.1) 9 (11.7) 14 (8.9)
Footnote for Table 2.
*Comparison between Megacolon vs Indeterminate.
**Comparison between ECG alteration vs Indeterminate.
fComparison between (ECG+ &/or Megacolon+) vs Indeterminate.
QLinkage Disequilibrium group of HLA-DRB1*03:01-MICB*008-B*08:01-A*01:01 as shown in Table 3.
doi:10.1371/journal.pntd.0001587.t002
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DRB1*03 haplotype that is associated with several diseases such
as allergy and viral infectious diseases [39]. It was not significantly
associated with Chagas. However, HLA-A*01:01 also showed a
decreased frequency in the megacolon patients. Whole sequencing
of the class III region of the associated haplotypes would be the
next target for clarification of any genetic resistance.
We have no information relating to the immunological
characteristics of the individuals who poscessed those haplotypes
that might be associated with lymphocyte activation during a
chronic infection. We did, however, analyze the relationship
between individuals’ specific antibody titers and their HLA alleles
(data not shown) but there was no clear correlation. About 7.1% of
the seropositive indeterminate individuals were estimated to carry
this haplotype; therefore further to identify its characteristic
immunological function is feasible. To our knowledge, this is the
first report of resistant HLA haplotype association with chronic
Chagas diagnosed by the active examination of silent colon lesion.
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